In fact, inhibition of both pathways triggers the suppression of c-MYC protein, effectively reducing proliferation in a mouse model of KRAS-driven CRC.149 Likewise, inhibition of eIF4E also mitigates the overexpression of MYC in PDAC mutated in KRAS.150. The gene discussed is KRAS; the disease is colorectal carcinoma.